Literature DB >> 17200186

Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.

Gary Hin-Fai Yam1, Katarina Gaplovska-Kysela, Christian Zuber, Jürgen Roth.   

Abstract

Primary open-angle glaucoma with elevated intraocular pressure is a leading cause of blindness worldwide. Mutations of myocilin are known to play a critical role in the manifestation of the disease. Misfolded mutant myocilin forms secretion-incompetent intracellular aggregates. The block of myocilin secretion was proposed to alter the extracellular matrix environment of the trabecular meshwork, with subsequent impediment of aqueous humor outflow leading to elevated intraocular pressure. However, the molecular pathogenesis of myocilin-caused glaucoma is poorly defined. In this study, we show that heteromeric complexes composed of wild-type and mutant myocilin were retained in the rough endoplasmic reticulum, aggregating to form inclusion bodies typical of Russell bodies. The presence of myocilin aggregates induced the unfolded protein response proteins BiP and phosphorylated endoplasmic reticulum-localized eukaryotic initiation factor-2alpha kinase (PERK) with the subsequent activation of caspases 12 and 3 and expression of C/EBP homologous protein (CHOP)/GADD153, leading to apoptosis. Our findings identify endoplasmic reticulum stress-induced apoptosis as a pathway to explain the reduction of trabecular meshwork cells in patients with myocilin-caused glaucoma. As a consequence, the phagocytotic capacity of the remaining trabecular meshwork cell population would be insufficient for effective cleaning of aqueous humor, constituting a major pathogenetic factor for the development of increased intraocular pressure in primary open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200186      PMCID: PMC1762699          DOI: 10.2353/ajpath.2007.060806

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  83 in total

1.  Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.

Authors:  M F Adam; A Belmouden; P Binisti; A P Brézin; F Valtot; A Béchetoille; J C Dascotte; B Copin; L Gomez; A Chaventré; J F Bach; H J Garchon
Journal:  Hum Mol Genet       Date:  1997-11       Impact factor: 6.150

2.  Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucoma.

Authors:  J Morissette; C Clépet; S Moisan; S Dubois; E Winstall; D Vermeeren; T D Nguyen; J R Polansky; G Côté; J L Anctil; M Amyot; M Plante; P Falardeau; V Raymond
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

3.  Delta F508 CFTR localizes in the endoplasmic reticulum-Golgi intermediate compartment in cystic fibrosis cells.

Authors:  A Gilbert; M Jadot; E Leontieva; S Wattiaux-De Coninck; R Wattiaux
Journal:  Exp Cell Res       Date:  1998-07-10       Impact factor: 3.905

4.  Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome.

Authors:  J Gottanka; C Flügel-Koch; P Martus; D H Johnson; E Lütjen-Drecoll
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-11       Impact factor: 4.799

Review 5.  Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.

Authors:  P S Kim; P Arvan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

6.  Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ.

Authors:  Y Matsumoto; D H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-08       Impact factor: 4.799

7.  Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A)

Authors:  W L Alward; J H Fingert; M A Coote; A T Johnson; S F Lerner; D Junqua; F J Durcan; P J McCartney; D A Mackey; V C Sheffield; E M Stone
Journal:  N Engl J Med       Date:  1998-04-09       Impact factor: 91.245

8.  Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma.

Authors:  J L Wiggs; R R Allingham; D Vollrath; K H Jones; M De La Paz; J Kern; K Patterson; V L Babb; E A Del Bono; B W Broomer; M A Pericak-Vance; J L Haines
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

9.  ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies.

Authors:  Laura Mattioli; Tiziana Anelli; Claudio Fagioli; Carlo Tacchetti; Roberto Sitia; Caterina Valetti
Journal:  J Cell Sci       Date:  2006-05-30       Impact factor: 5.285

10.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

View more
  66 in total

1.  Myocilin levels in primary open-angle glaucoma and pseudoexfoliation glaucoma human aqueous humor.

Authors:  Kyle G Howell; Anne M Vrabel; Uttio Roy Chowdhury; William Daniel Stamer; Michael P Fautsch
Journal:  J Glaucoma       Date:  2010-12       Impact factor: 2.503

2.  Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Yiming Wang; Iramofu M Dominic; Carol K Hall; Raquel L Lieberman
Journal:  Biochemistry       Date:  2019-03-12       Impact factor: 3.162

3.  Expression of mutant Ins2C96Y results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells.

Authors:  Jing-Yu Fan; Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-07-24       Impact factor: 4.304

Review 4.  The role of proteolytic cellular systems in trabecular meshwork homeostasis.

Authors:  Paloma B Liton; Pedro Gonzalez; David L Epstein
Journal:  Exp Eye Res       Date:  2008-11-12       Impact factor: 3.467

5.  Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.

Authors:  Dustin J E Huard; Vincent M Crowley; Yuhong Du; Ricardo A Cordova; Zheying Sun; Moya O Tomlin; Chad A Dickey; John Koren; Laura Blair; Haian Fu; Brian S J Blagg; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2018-02-20       Impact factor: 5.100

Review 6.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

7.  The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.

Authors:  J Nicole Burns; Katherine C Turnage; Chandler A Walker; Raquel L Lieberman
Journal:  Biochemistry       Date:  2011-06-09       Impact factor: 3.162

8.  Simulations and Experiments Delineate Amyloid Fibrilization by Peptides Derived from Glaucoma-Associated Myocilin.

Authors:  Yiming Wang; Yuan Gao; Shannon E Hill; Dustin J E Huard; Moya O Tomlin; Raquel L Lieberman; Anant K Paravastu; Carol K Hall
Journal:  J Phys Chem B       Date:  2018-05-21       Impact factor: 2.991

9.  Differential effects of myocilin and optineurin, two glaucoma genes, on neurite outgrowth.

Authors:  Takahisa Koga; Xiang Shen; Jeong-Seok Park; Ye Qiu; Bum-Chan Park; Rajalekshmy Shyam; Beatrice Y J T Yue
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

10.  RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.

Authors:  Mao Li; Jianjiang Xu; Xueli Chen; Xinghuai Sun
Journal:  Diagn Pathol       Date:  2009-12-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.